2.3
2022

Chronic spontaneous urticaria treated with omalizumab: what differentiates early from late responders?

Show more: Authors information and Publication history
Authors Information

Allergology clinic, Clinica San Carlo, Paderno Dugnano, Milan, Italy

History

:
Published online: 07 January 2021
Accepted: 15 April 2020
Received: 26 March 2020

KEY WORDS
Chronic urticaria; omalizumab; biomarkers; IgE; D-dimer; therapy

Table of Content: Vol. 53 (No. 1) 2021 January

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024